Peptron, Inc. (KOSDAQ:087010)

South Korea flag South Korea · Delayed Price · Currency is KRW
166,200
-6,700 (-3.88%)
May 9, 2025, 3:30 PM KST
463.92%
Market Cap 4.03T
Revenue (ttm) 3.15B
Net Income (ttm) -22.03B
Shares Out 23.30M
EPS (ttm) -1,061.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 138,167
Average Volume 436,153
Open 171,200
Previous Close 172,900
Day's Range 166,200 - 173,000
52-Week Range 27,100 - 191,500
Beta 0.78
RSI 64.44
Earnings Date n/a

About Peptron

Peptron, Inc. engages in the development of peptide-based medicines. The company’s technologies include long acting; and SmartDepot, an ultrasonic spray drying technology for the preparation of sustained release injectable microsphere formulation of drug. It develops PAb 001 for cancer therapy; SR-Exenatide (PT320) for Parkinson’s and other neurodegenerative disease; SR-Octreotide for the treatment of acromegaly; and Dernak filler for bioequivalence. Peptron, Inc. was founded in 1997 and is headquartered in Daejeon, South Korea. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1997
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 087010
Full Company Profile

Financial Performance

In 2024, Peptron's revenue was 3.15 billion, a decrease of -5.68% compared to the previous year's 3.34 billion. Losses were -22.03 billion, 38.4% more than in 2023.

Financial Statements

News

There is no news available yet.